Daily Newsletter

25 September 2024

Daily Newsletter

25 September 2024

Human in Motion Robotics secures Canadian approval for XoMotion exoskeleton

The XoMotion will revolutionise rehabilitation for patients suffering from spinal cord injuries and neurological disorders.

RanjithKumar Dharma September 25 2024

Robotic mobility and humanoid technology company Human in Motion Robotics has received regulatory approval to market and sell the XoMotion exoskeleton in Canada.

It is claimed to be the first advanced medical exoskeleton with self-balancing and hands-free capabilities available in the country.

This technology is said to transform rehabilitation for patients with stroke, spinal cord injuries and other neurological conditions.

XoMotion can replicate natural human movements, offering inherent operation for patients and therapists.

It is designed to alleviate the physical demands on therapists during rehabilitation sessions by providing lifting, mobilising, assisting and training support to patients, thereby enhancing the efficiency and safety of rehabilitation programmes.

The features of XoMotion include self-balancing for stability and safety, hands-free operation for natural movement, omnidirectional functionality for complex tasks, versatility for various conditions and stages of injury, and increased safety by reducing the therapists' physical burden.

Human in Motion Robotics CEO Siamak Arzanpour said: “With XoMotion, we are setting a new standard in rehabilitation technology. Our exoskeleton not only empowers patients by facilitating natural and functional movement but also supports therapists by reducing the physical demands of their work.

“Gaining regulatory approval from Health Canada is a crucial step towards our goal of global accessibility, and we are committed to continuing this progress in other key markets.”

Human in Motion Robotics has also secured its Medical Devices Establishment License, enabling the marketing and sale of XoMotion in Canada.

The company is now setting its sights on obtaining clearance in other key markets, including the US, Asia, and the European Union (EU).

XoMotion is currently available for acquisition by rehabilitation and research facilities in Canada and is also accessible to global scientific investigators who conduct robotics research.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close